Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Manish Muhuri
Institution:
University of Massachusetts Chan Medical School
Observed institutions:
Agency for Science, Technology and Research,
University of Massachusetts Chan Medical School,
Institute of Medical Biology
ORCID:
0000-0003-3265-903X
Observed ORCID:
0000-0003-3265-903X
OpenAlex ID:
A5067369102
Engineering adeno-associated viral vectors to evade innate immune and inflammatory responses
2021
·
Ying Kai Chan
, Sean K. Wang
, et al.
·
Science Translational Medicine
·
233
Overcoming innate immune barriers that impede AAV gene therapy vectors
2021
·
Manish Muhuri
, Yukiko Maeda
, et al.
·
Journal of Clinical Investigation
·
226
PDF
Durability of transgene expression after rAAV gene therapy
2022
·
Manish Muhuri
, Daniel I. Levy
, et al.
·
Molecular Therapy
·
172
PDF
Docosanoic acid conjugation to siRNA enables functional and safe delivery to skeletal and cardiac muscles
2020
·
Annabelle Biscans
, Jillian Caiazzi
, et al.
·
Molecular Therapy
·
78
PDF
EGF hijacks miR-198/FSTL1 wound-healing switch and steers a two-pronged pathway toward metastasis
2017
·
Gopinath M. Sundaram
, Hisyam M. Ismail
, et al.
·
The Journal of Experimental Medicine
·
74
Circumventing cellular immunity by miR142-mediated regulation sufficiently supports rAAV-delivered OVA expression without activating humoral immunity
2019
·
Yuanyuan Xiao
, Manish Muhuri
, et al.
·
JCI Insight
·
64
PDF
Novel Combinatorial MicroRNA-Binding Sites in AAV Vectors Synergistically Diminish Antigen Presentation and Transgene Immunity for Efficient and Stable Transduction
2021
·
Manish Muhuri
, Wei Zhan
, et al.
·
Frontiers in Immunology
·
53
Divalent siRNAs are bioavailable in the lung and efficiently block SARS-CoV-2 infection
2023
·
Vignesh N. Hariharan
, Minwook Shin
, et al.
·
Proceedings of the National Academy of Sciences
·
49
Modulating immune responses to AAV by expanded polyclonal T-regs and capsid specific chimeric antigen receptor T-regulatory cells
2021
·
Motahareh Arjomandnejad
, Katelyn Sylvia
, et al.
·
Molecular Therapy — Methods & Clinical Development
·
48
PDF
MicroRNA-138 is a Prognostic Biomarker for Triple-Negative Breast Cancer and Promotes Tumorigenesis via TUSC2 repression
2019
·
Srikanth Nama
, Manish Muhuri
, et al.
·
Scientific Reports
·
44
PDF
Vectored Immunotherapeutics for Infectious Diseases: Can rAAVs Be The Game Changers for Fighting Transmissible Pathogens?
2021
·
Wei Zhan
, Manish Muhuri
, et al.
·
Frontiers in Immunology
·
37
PDF
C/EBPβ mediates RNA polymerase III-driven transcription of oncomiR-138 in malignant gliomas
2017
·
Federica Di Pascale
, Srikanth Nama
, et al.
·
Nucleic Acids Research
·
21
PDF
Editorial: Immunogenicity and toxicity of AAV gene therapy
2023
·
Allison Bradbury
, David Markusic
, et al.
·
Frontiers in Immunology
·
14
PDF
Oncolytic Virus Alphavirus M1: A New and Promising Weapon to Fight Cancer
2021
·
Manish Muhuri
, Guangping Gao
·
Human Gene Therapy
·
8
Is smaller better? Vaccine targeting recombinant receptor-binding domain might hold the key for mass production of effective prophylactics to fight the COVID-19 pandemic
2020
·
Manish Muhuri
, Guangping Gao
·
Signal Transduction and Targeted Therapy
·
4
PDF
How long do the effects of gene therapy based on adeno-associated virus last? A plain language summary
2024
·
Tara Moroz
, Manish Muhuri
, et al.
·
Future Rare Diseases
·
2
Membranous Bubbles: High-Purity and High-Titer Exosomes as the Potential Solution for Adeno-Associated Viruses to Evade Neutralization?
2021
·
Manish Muhuri
, Guangping Gao
·
Human Gene Therapy
·
2
Show more works
View as search
Works count:
17
Citation count:
1,126
H-index:
13
I10-index:
13
Year
Topic
Type